Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HRASLS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RARRES3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLA2G16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LGALS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRASLS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf95 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on